Biodesix to present at the h.c. wainwright global investment conference

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced scott hutton, chief executive officer of biodesix, will present virtually at the h.c. wainwright global investment conference being held may 23-25, 2022. h.c. wainwright global investment conference date: tuesday, may 24, 2022 pre-recorded on-demand presentation available beginning at 7:00 am et the on-demand presentation will be availa
BDSX Ratings Summary
BDSX Quant Ranking